Literature DB >> 27316989

AlphaScreen-Based Assays: Ultra-High-Throughput Screening for Small-Molecule Inhibitors of Challenging Enzymes and Protein-Protein Interactions.

Adam Yasgar1, Ajit Jadhav1, Anton Simeonov1, Nathan P Coussens2.   

Abstract

AlphaScreen technology has been routinely utilized in high-throughput screening assays to quantify analyte accumulation or depletion, bimolecular interactions, and post-translational modifications. The high signal-to-background, dynamic range, and sensitivity associated with AlphaScreens as well as the homogenous assay format and reagent stability make the technology particularly well suited for high-throughput screening applications. Here, we describe the development of AlphaScreen assays to identify small-molecule inhibitors of enzymes and protein-protein interactions using the highly miniaturized 1536-well format. The subsequent implementation of counter assays to identify false-positive compounds is also discussed.

Entities:  

Keywords:  AlphaLISA; AlphaScreen; Assay; ELISA; Enzyme; HTS; High-throughput screening; Protein-protein interaction

Mesh:

Substances:

Year:  2016        PMID: 27316989      PMCID: PMC5444910          DOI: 10.1007/978-1-4939-3673-1_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  23 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

Authors:  Jonathan B Baell; Georgina A Holloway
Journal:  J Med Chem       Date:  2010-04-08       Impact factor: 7.446

3.  A multimarker approach to diagnose and stratify heart failure.

Authors:  Yunxia Wan; Xi Xhang; John J Atherton; Karam Kostner; Goce Dimeski; Chamindie Punyadeera
Journal:  Int J Cardiol       Date:  2014-12-23       Impact factor: 4.164

4.  Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1.

Authors:  Catherine Z Chen; Krzysztof Sobczak; Jason Hoskins; Noel Southall; Juan J Marugan; Wei Zheng; Charles A Thornton; Christopher P Austin
Journal:  Anal Bioanal Chem       Date:  2012-01-05       Impact factor: 4.142

5.  Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.

Authors:  E F Ullman; H Kirakossian; S Singh; Z P Wu; B R Irvin; J S Pease; A C Switchenko; J D Irvine; A Dafforn; C N Skold
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

6.  A high-throughput screening assay for determining cellular levels of total tau protein.

Authors:  Seameen J Dehdashti; Wei Zheng; Joel R Gever; Robert Wilhelm; Dac-Trung Nguyen; Gurusingham Sittampalam; John C McKew; Christopher P Austin; Stanley B Prusiner
Journal:  Curr Alzheimer Res       Date:  2013-09       Impact factor: 3.498

7.  A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors.

Authors:  Amy M Quinn; Abdellah Allali-Hassani; Masoud Vedadi; Anton Simeonov
Journal:  Mol Biosyst       Date:  2010-03-02

8.  A novel immunoassay for the quantization of CYFRA 21-1 in human serum.

Authors:  An He; Tian-Cai Liu; Zhi-Ning Dong; Zhi-Qi Ren; Jing-Yuan Hou; Ming Li; Ying-Song Wu
Journal:  J Clin Lab Anal       Date:  2013-07       Impact factor: 2.352

9.  The use of AlphaScreen technology in HTS: current status.

Authors:  Richard M Eglen; Terry Reisine; Philippe Roby; Nathalie Rouleau; Chantal Illy; Roger Bossé; Martina Bielefeld
Journal:  Curr Chem Genomics       Date:  2008-02-25

10.  Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.

Authors:  Lea Cunningham; Steven Finckbeiner; R Katherine Hyde; Noel Southall; Juan Marugan; Venkat R K Yedavalli; Seameen Jean Dehdashti; William C Reinhold; Lemlem Alemu; Ling Zhao; Jing-Ruey Joanna Yeh; Raman Sood; Yves Pommier; Christopher P Austin; Kuan-Teh Jeang; Wei Zheng; Paul Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-21       Impact factor: 11.205

View more
  37 in total

1.  Detecting Secretory Proteins by Acoustic Droplet Ejection in Multiplexed High-Throughput Applications.

Authors:  Michael J Iannotti; Ryan MacArthur; Richard Jones; Dingyin Tao; Ilyas Singeç; Sam Michael; James Inglese
Journal:  ACS Chem Biol       Date:  2019-02-14       Impact factor: 5.100

2.  Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes.

Authors:  Kfir Sharabi; Hua Lin; Clint D J Tavares; John E Dominy; Joao Paulo Camporez; Rachel J Perry; Roger Schilling; Amy K Rines; Jaemin Lee; Marc Hickey; Melissa Bennion; Michelle Palmer; Partha P Nag; Joshua A Bittker; José Perez; Mark P Jedrychowski; Umut Ozcan; Steve P Gygi; Theodore M Kamenecka; Gerald I Shulman; Stuart L Schreiber; Patrick R Griffin; Pere Puigserver
Journal:  Cell       Date:  2017-03-23       Impact factor: 41.582

3.  Interaction of the N terminus of ADP-ribosylation factor with the PH domain of the GTPase-activating protein ASAP1 requires phosphatidylinositol 4,5-bisphosphate.

Authors:  Neeladri Sekhar Roy; Xiaoying Jian; Olivier Soubias; Peng Zhai; Jessica R Hall; Jessica N Dagher; Nathan P Coussens; Lisa M Jenkins; Ruibai Luo; Itoro O Akpan; Matthew D Hall; R Andrew Byrd; Marielle E Yohe; Paul A Randazzo
Journal:  J Biol Chem       Date:  2019-10-06       Impact factor: 5.157

4.  A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155.

Authors:  Bushra Husain; Sree R Ramani; Eugene Chiang; Isabelle Lehoux; Sairupa Paduchuri; Tia A Arena; Ashka Patel; Blair Wilson; Pamela Chan; Yvonne Franke; Athena W Wong; Jennie R Lill; Shannon J Turley; Lino C Gonzalez; Jane L Grogan; Nadia Martinez-Martin
Journal:  Mol Cell Proteomics       Date:  2019-07-15       Impact factor: 5.911

5.  TF-containing MUC1 glycopeptides fail to entice Galectin-1 recognition of tumor-associated Thomsen-Freidenreich (TF) antigen (CD176) in solution.

Authors:  Forrest G FitzGerald; Maria C Rodriguez Benavente; Camelia Garcia; Yaima Rivero; YashoNandini Singh; Hongjie Wang; Gregg B Fields; Maré Cudic
Journal:  Glycoconj J       Date:  2020-10-01       Impact factor: 2.916

6.  Quantitative high-throughput screening identifies cytoprotective molecules that enhance SUMO conjugation via the inhibition of SUMO-specific protease (SENP)2.

Authors:  Joshua D Bernstock; Daniel Ye; Jayden A Smith; Yang-Ja Lee; Florian A Gessler; Adam Yasgar; Jennifer Kouznetsova; Ajit Jadhav; Zhuoran Wang; Stefano Pluchino; Wei Zheng; Anton Simeonov; John M Hallenbeck; Wei Yang
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

7.  Luminescence complementation assay for measurement of binding to protein C-termini in live cells.

Authors:  Cory M Nadel; Xu Ran; Jason E Gestwicki
Journal:  Anal Biochem       Date:  2020-09-10       Impact factor: 3.365

8.  INI1/SMARCB1 Rpt1 domain mimics TAR RNA in binding to integrase to facilitate HIV-1 replication.

Authors:  Updesh Dixit; Savita Bhutoria; Xuhong Wu; Liming Qiu; Menachem Spira; Sheeba Mathew; Richard Harris; Lucas J Adams; Sean Cahill; Rajiv Pathak; P Rajesh Kumar; Minh Nguyen; Seetharama A Acharya; Michael Brenowitz; Steven C Almo; Xiaoqin Zou; Alasdair C Steven; David Cowburn; Mark Girvin; Ganjam V Kalpana
Journal:  Nat Commun       Date:  2021-05-12       Impact factor: 14.919

Review 9.  Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases.

Authors:  Monimoy Banerjee; Ishita Hatial; Bradley M Keegan; Brian S J Blagg
Journal:  Pharmacol Ther       Date:  2020-11-24       Impact factor: 12.310

10.  Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor.

Authors:  Bruce J MacLachlan; Georgina H Mason; Alexander Greenshields-Watson; Frederic Triebel; Awen Gallimore; David K Cole; Andrew Godkin
Journal:  Eur J Immunol       Date:  2020-10-09       Impact factor: 6.688

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.